Centogene N.V. (NASDAQ:CNTG) Q1 2020 Earnings Conference Call - Final Transcript

Jun 15, 2020 • 08:00 am ET


Centogene N.V. (NASDAQ:CNTG) Q1 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Ladies and gentlemen, thank you for standing by, and welcome to the Centogene First Quarter 2020 Earnings Results Conference Call. [Operator Instructions] And I'd now turn the conference over to your speaker today, Sun Kim. Please go ahead.

Sun Kim

Thank you. Hello and welcome. Thank you for joining us to discuss our Q1 2020 results, which were issued earlier today. You can view this presentation and the related press release on Centogene's website. For those not able to view the webcast, you can find the relevant slides on www.investors.centogene.com. Our speakers today are Centogene's Chief Executive Officer, Professor Arndt Rolfs; and Richard Stoffelen, Centogene's Chief Financial Officer.

Before we begin, please refer to Slide 2 of our presentation, which provides information about certain statements to be made today that may be considered forward-looking statements within the meaning of the US securities laws, including those regarding our strategic plans, development program and future financial results. Statements made during this call that are not historical statements may be forward-looking statements, and as such, may be subject to risks and uncertainties, which, if they materialize, could materially affect our actual results. The forward-looking statements in this presentation speak only as of today, and we undertake no obligation to update or revise any of the statements to reflect future events or developments, except as required by the law. Additional information regarding these statements appears in our SEC filings.

Following our presentation, we will also open up the call to Q&A. We kindly ask that you ask only a maximum of three questions. I will now hand the presentation over to Arndt. Please turn to Slide 3.

Arndt Rolfs

Thank you, Sun, and hello, everyone. Thank you for joining our call today, especially during these unprecedented times. We hope everyone is staying healthy and safe, and our thoughts are with those affected by the COVID-19 pandemic.

Before we dive into our Q1 2020 performance, let me quickly update you on the current situation regarding COVID-19 for Centogene. As we publicly announced in April, we have reopened our offices in a carefully measured manner, providing all of our employees with viral testing twice per week, gives us the confidence that we have better management over the situation as our employees have begun to return to the office. We also strengthened some safety protocols to be extra careful, and for the most part, Centogene is fully operational.

Now, let us tell you about our Q1 2020 performance and also provide you with a broader update on our business. I'll start by touching upon key aspects of our business. And then, Richard will take you through the financials.

Let's turn to Slide 4. Before we get into the performance of the business, let me take this opportunity to remind you of Centogene's scope. I think it is always good to put things into context. And for me, that means looking at recent achievements with our long-term goal in mind. Our ultimate goal is to provide precise medical diagnosis of inherited diseases at